CagriSema, which is a combination of cagrilintide 2.4-milligram and semaglutide 2.4-mg doses, is being developed so people have a better choice for a weight-loss drug when the patents on Ozempic ...

cagrilintide 2.4-milligram and semaglutide 2.4-mg doses, as opposed to other GLP-1 weight-loss drugs, like Ozempic and Wegovy. The idea is to offer a better choice for a weight-loss drug when the ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing ...

Eli Lilly reduced the monthly price of lower-dosage vials of Zepbound by $50 for cash-paying consumers through its LillyDirect online store. Patients can now purchase a monthly supply of 2.5 mg ...

A blockbuster diabetes drug will soon be available to Indian patients at a tenth of its cost, as its patent expires. At least four Indian generics players have launched cheaper variants of the ...

BERLIN (Reuters) - French drugmaker Sanofi (NASDAQ:SNY) is nearing a decision to invest between 1.3 billion and 1.5 billion ...

Wellbutrin may be an option for adults with ADHD who don’t respond well to stimulants or have co-occurring mental health conditions. Wellbutrin is the brand name for the antidepressant drug ...

When your blood sugar levels fall within the recommended ranges, it’s a sign your diabetes treatment and management plan is working. You and your doctor can determine your exact blood sugar ...

For severe symptoms take 4-6 Gynovite tablets daily; for lesser symptoms ... Supplementing the diet with three mg of boron a day has been found to reduce calcium loss in urine by a dramatic ...

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...